QIU Luyao, TANG Wenjing, YANG Lu, LYU Ge, CHEN Junjie, SUN Gan, WANG Yanping, ZHOU Lina, AN Yunfei, ZHANG Zhiyong, TANG Xuemei, ZHAO Xiaodong, DU Hongqiang. Clinical Phenotype and Immunological Characteristics of A Patient with De Novo Heterozygous Mutation of PTEN[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 373-378. DOI: 10.12290/xhyxzz.2023-0023
Citation: QIU Luyao, TANG Wenjing, YANG Lu, LYU Ge, CHEN Junjie, SUN Gan, WANG Yanping, ZHOU Lina, AN Yunfei, ZHANG Zhiyong, TANG Xuemei, ZHAO Xiaodong, DU Hongqiang. Clinical Phenotype and Immunological Characteristics of A Patient with De Novo Heterozygous Mutation of PTEN[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 373-378. DOI: 10.12290/xhyxzz.2023-0023

Clinical Phenotype and Immunological Characteristics of A Patient with De Novo Heterozygous Mutation of PTEN

Funds: 

National Natural Science Foundation of China 81974255

More Information
  • Corresponding author:

    ZHAO Xiaodong, E-mail: zhaoxd530@aliyun.com

    DU Hongqiang, E-mail: doctordo@aliyun.com

  • Received Date: January 08, 2023
  • Accepted Date: February 09, 2023
  • Available Online: March 20, 2023
  • Issue Publish Date: March 29, 2023
  •   Objective  To analyze the clinical phenotype and immunological characteristics of a patient with heterozygous mutation of PTEN and enrich the clinical phenotypes related to PTEN mutation.
      Methods  A retrospective analysis of the clinical data of a patient with PTEN heterozygous mutation admitted to the Children's Hospital of Chongqing Medical University was conducted. Peripheral venous blood was extracted for medical whole-exome comprehensive detection, and the PTEN mutation was confirmed by Sanger sequencing. Flow cytometry was applied to detect the lymphocyte subsets and immunophenotype of the patient. The expression level of PTEN protein in peripheral blood mononuclear cells was detected by Western blot, and the healthy control was the patient's father.
      Results  The patient was a boy of 1 year and 4 months, with macrocephaly (head circumference > P99), verrucous epidermal nevus, delayed psychomotor development and delayed language learning as the main manifestations. Gene sequencing revealed a de novo heterozygous mutation of PTEN c.388C > T(p.R130X). Reduced expression of PTEN protein was observed in peripheral blood mononuclear cells of the patient. For immunological characteristics, the IgA level mildly decreased(0.177 g/L), with increased counts of terminally differentiated memory CD4+ T cells, terminally differentiated memory CD8+ T cells, transitional B cells, but phosphorylation of PI3K/Akt/mTOR pathway in T cells was normal. The patient mainly manifested as PTEN hamartoma tumor syndrome related phenotype, without any classic activated phosphatidylinositol 3-kinase δ syndrome-like phenotype.
      Conclusions  This patient has a de novo heterozygous mutation of PTEN c.388C > T(p.R130X), which has not been previously reported in China. This article could enrich clinicians' understanding of the disease and assist clinical diagnosis and treatment.
  • [1]
    Pilarski R. PTEN Hamartoma Tumor Syndrome: A Clinical Overview[J]. Cancers (Basel), 2019, 11: 844. DOI: 10.3390/cancers11060844
    [2]
    Celebi JT, Tsou HC, Chen FF, et al. Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTEN[J]. J Med Genet, 1999, 36: 360-364.
    [3]
    Tsujita Y, Mitsui-Sekinaka K, Imai K, et al. Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome-like immunodeficiency[J]. J Allergy Clin Immunol, 2016, 138: 1672-1680. DOI: 10.1016/j.jaci.2016.03.055
    [4]
    Ding Y, Zhou L, Xia Y, et al. Reference values for peripheral blood lymphocyte subsets of healthy children in China[J]. J Allergy Clin Immunol, 2018, 142: 970-973. DOI: 10.1016/j.jaci.2018.04.022
    [5]
    Pilarski R, Burt R, Kohlman W, et al. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria[J]. J Natl Cancer Inst, 2013, 105: 1607-1616. DOI: 10.1093/jnci/djt277
    [6]
    Daly MB, Pilarski R, Berry M, et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017[J]. J Natl Compr Canc Netw, 2017, 15: 9-20. DOI: 10.6004/jnccn.2017.0003
    [7]
    Busa T, Milh M, Degardin N, et al. Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome[J]. Eur J Paediatr Neurol, 2015, 19: 188-192. DOI: 10.1016/j.ejpn.2014.11.012
    [8]
    Coulter TI, Chandra A, Bacon CM, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study[J]. J Allergy Clin Immunol, 2017, 139: 597-606. DOI: 10.1016/j.jaci.2016.06.021
    [9]
    Larbi A, Fulop T. From "truly naïve" to "exhausted senescent" T cells: when markers predict functionality[J]. Cytometry A, 2014, 85: 25-35. DOI: 10.1002/cyto.a.22351
    [10]
    Hand TW, Cui W, Jung YW, et al. Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival[J]. Proc Natl Acad Sci USA, 2010, 107: 16601-16606. DOI: 10.1073/pnas.1003457107
    [11]
    Zhou Y, Zhang Y, Han J, et al. Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases[J]. J Transl Med, 2020, 18: 131. DOI: 10.1186/s12967-020-02289-w
    [12]
    Leslie NR, Longy M. Inherited PTEN mutations and the prediction of phenotype[J]. Semin Cell Dev Biol, 2016, 52: 30-38. DOI: 10.1016/j.semcdb.2016.01.030
    [13]
    Chen L, Guo D. The functions of tumor suppressor PTEN in innate and adaptive immunity[J]. Cell Mol Immunol, 2017, 14: 581-589. DOI: 10.1038/cmi.2017.30
    [14]
    Nelen MR, van Staveren WC, Peeters EA, et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease[J]. Hum Mol Genet, 1997, 6: 1383-1387. DOI: 10.1093/hmg/6.8.1383
    [15]
    Mester J, Eng C. Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome[J]. J Surg Oncol, 2015, 111: 125-130. DOI: 10.1002/jso.23735
    [16]
    Daly MB, Pilarski R, Yurgelun MB, et al. NCCN Guide-lines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020[J]. J Natl Compr Canc Netw, 2020, 18: 380-391. DOI: 10.6004/jnccn.2020.0017
    [17]
    Podsypanina K, Lee RT, Politis C, et al. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice[J]. Proc Natl Acad Sci USA, 2001, 98: 10320-10325. DOI: 10.1073/pnas.171060098
    [18]
    Squarize CH, Castilho RM, Gutkind JS. Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin[J]. Cancer Res, 2008, 68: 7066-7072. DOI: 10.1158/0008-5472.CAN-08-0922
    [19]
    Ross-Innes CS, Becq J, Warren A, et al. Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma[J]. Nat Genet, 2015, 47: 1038-1046. DOI: 10.1038/ng.3357
    [20]
    Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma[J]. CA Cancer J Clin, 2013, 63: 232-248. DOI: 10.3322/caac.21185
  • Related Articles

    [1]PAN Yuhui, SANG Wentao, BIAN Yuan, XU Feng. Sudden Cardiac Death in Hypertrophic Cardiomyopathy: Hig-risk Factors and Prevention[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 465-471. DOI: 10.12290/xhyxzz.2022-0627
    [2]LI Yi, XU Yingchun. A New Chapter in the COVID-19 Pandemic: the Characteristics of Omicron Variant and A New Step for Scientific Epidemic Prevention and Control[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 9-17. DOI: 10.12290/xhyxzz.2022-0697
    [3]XU Fen, ZHOU Zhou. Heart Failure: Prevention and Treatment are Indispensable[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 953-957. DOI: 10.12290/xhyxzz.2022-0440
    [4]ZHAO Weigang. Interpretation on Clinical Guidelines for Prevention and Treatment of Type 2 Diabetes Mellitus in the Elderly in China (2022 Edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 574-580. DOI: 10.12290/xhyxzz.2022-0199
    [5]Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 902-912. DOI: 10.12290/xhyxzz.2021-0555
    [6]Di ZHONG, Bo WU. Will the Strategies of Stroke Prevention Change with the New Diagnostic Standard of Hypertension?[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 103-107. DOI: 10.3969/j.issn.1674-9081.2019.02.003
    [7]Ying-xian SUN. Suggestion on China Mode of Prevention, Diagnosis and Treatment of Hypertension[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 97-99. DOI: 10.3969/j.issn.1674-9081.2019.02.001
    [8]Fenglin Liu, Jing Qin. From Guidelines to Practice: Analysis of Guidelines for Prevention and Management of Perioperative Venous Thrombosis in General Surgery in China[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(2): 144-149. DOI: 10.3969/j.issn.1674-9081.2018.02.008
    [9]Ming-sheng MA, Xü-de ZHANG, Min WEI, Shi-min ZHAO, Zheng-qing QIU. Efficacy of Low Dose Corticosteroid Therapy in Duchenne Muscular Dystrophy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 384-388. DOI: 10.3969/j.issn.1674-9081.2014.04.006
    [10]Ying ZHANG, Jin-song GAO, Jun-tao LIU, Hai-yuan LIU, Ying-na SONG, Xiao-ming GONG, Zhi-jing SUN. Effectiveness of B-lynch Suture in Treatment and Prevention of Postpartum Hemorrhage[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(2): 174-177. DOI: 10.3969/j.issn.1674-9081.2013.02.019
  • Cited by

    Periodical cited type(9)

    1. 张华俊,袁建娜,王薇. 维生素D联合膳食管理对妊娠期糖尿病患者血糖控制及妊娠结局的影响. 中国食物与营养. 2024(03): 56-59 .
    2. 俎晓霞,陈肖静,申慧军,张鸣华. 维生素D缺乏孕妇规范补充维生素D预防妊娠期代谢性疾病效果及其妊娠结局分析. 中国计划生育学杂志. 2024(06): 1389-1392 .
    3. 宋振香,孙慧芹,孙胜玉. 血清25羟维生素D与妊娠期糖尿病胰岛素抵抗的相关性分析. 中国卫生标准管理. 2024(20): 13-16 .
    4. 丁德胜,王龙琼,何小玲,庞文茜,李韵唱,王元楷,周凤兰,蔡甜,陈科伟. 基于UPLC/Q-TOF-MS技术分析人乳中VD及其酯类分布规律. 食品科学. 2023(10): 324-331 .
    5. 李莉,赵向阳. 妊娠期糖尿病孕妇25-羟维生素D、Hcy与胰岛素抵抗的相关性分析. 贵州医药. 2023(05): 693-694 .
    6. 孟永杰,陶文远,王圆,郭俊杰. 维生素D与常见内分泌疾病关系的研究进展. 中医临床研究. 2023(12): 138-144 .
    7. 杨旭博,赖建强. 维生素D与妊娠期糖尿病关系的研究进展. 中国食物与营养. 2022(07): 68-73 .
    8. 张宁,丁晓华,何瑞臻,周瑞,张雪芬. 维生素D在预防妊娠期糖尿病中的应用研究进展. 中国当代医药. 2022(27): 34-37 .
    9. 颜云华,张爱华,李宁,郦培昕,戴楠. 维生素D缺乏与妊娠期糖尿病发生的关系探讨. 现代医学. 2022(12): 1541-1545 .

    Other cited types(2)

Catalog

    Article Metrics

    Article views (2999) PDF downloads (40) Cited by(11)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close